Leaderboard

En | De
No articles selected!     View Cart  
You are here: Neurology » Multiple Sclerosis 16. September 2026
Search
medline.ch
Multiple Sclerosis
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2245  Previews Next
   
   Articles 1 - 20 / 44897  
   
Multicenter study of cladribine in relapsing-remitting multiple sclerosis in patients over 50 years.
Farm Hosp
Fortes-González MS, Herrero-Poch L, Pato-Pato A, Lorenzo-García M, Martínez López de Castro N, Grupo de Estudio de Esclerosis Múltiple de la Sociedade Galega de Neuroloxía.
PMID: 42744703 [PubMed - as supplied by publisher]


Effect of mesenchymal stem cells on peripheral immune cells in multiple sclerosis: results from an international phase 2 clinical trial.
Transplant Cell Ther
Schiavetti I, Freedman MS, Thebault S, Ivaldi F, Palmeri S, Furlan R, Uccelli A, Laroni A, MESEMS ancillary study group.
PMID: 42744029 [PubMed - as supplied by publisher]


Serum neurofilament light chain in multiple sclerosis: promise, pitfalls, and the path to clinical implementation.
Mult Scler Relat Disord
Alashger BK, Alnoiser SN, Kaltham AH, Ahmed AR, Elkattawy HA.
PMID: 42743806 [PubMed - as supplied by publisher]


Late-Onset Neutropenia After Rituximab in Multiple Sclerosis: Incidence, Predictors, and Outcomes in a Retrospective Multicenter Cohort.
Neurol Neuroimmunol Neuroinflamm
Hallberg S, Kallin S, Evertsson B, Boremalm M, de Flon P, Salzer J, Lycke J, Fink K, Svenningsson A.
PMID: 42743451 [PubMed - indexed for MEDLINE]


EBNA1(381-452) and Cross-Reactive Antibody Responses Reveal Immune Signatures in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
De Wit D, Beliën J, David M, Swinnen S, Dedoncker N, Yshii L, Dubois B.
PMID: 42743450 [PubMed - indexed for MEDLINE]


SARS-CoV-2 management strategies in B-Cell-depleted people with multiple sclerosis: from prevention to antiviral treatment.
Expert Rev Clin Immunol
Feige J, Hauer L, Sellner J.
PMID: 42741870 [PubMed - as supplied by publisher]


Correction: The relationship between motor and cognitive performance and cortical activity in patients with multiple sclerosis: a systematic review of functional nearinfrared spectroscopy studies.
Front Rehabil Sci
Sun H, Xing H, Hu K, Wu Z, Wu J.
PMID: 42741224 [PubMed]


Home-based cognitive telerehabilitation in multiple sclerosis: differential cognitive trajectories according to baseline impairment severity.
Front Behav Neurosci
Riccitelli GC, Sacco R, Beeching F, Mallucci G, Disanto G, Gobbi C, Zecca C.
PMID: 42741072 [PubMed]


Polyunsaturated Fatty Acid Supplementation in Multiple Sclerosis Management: A Scoping Review.
Nutrients
Oliveira R, Lopes CM, Silva C, Guerra RS.
PMID: 42739087 [PubMed - indexed for MEDLINE]


Apigenin as a Potential Modulator of Neuroinflammation in Multiple Sclerosis: A Review.
Biology (Basel)
Santana MR, Silva NN, de Oliveira JVR, Victor MM, Butt AM, Costa SL.
PMID: 42737977 [PubMed]


Plasma-Derived Extracellular Vesicle microRNAs in Multiple Sclerosis: An Exploratory Case-Control Study on Phenotypic Discrimination.
Int J Mol Sci
Vrînceanu O, Manu D, Maier S, B, Carstea AC, B.
PMID: 42737436 [PubMed - indexed for MEDLINE]


Development of a Mixed-Reality Application for Volitional Step Training in People With Multiple Sclerosis: Cross-Sectional Qualitative User-Centered Co-Design Study.
JMIR Serious Games
Perachiotti G, Busch IM, Vallefuoco E, D'Errico G, Moccaldi N, Straudi S, Arpaia P.
PMID: 42735903 [PubMed]


Platelet-activating factor in multiple sclerosis: From peripheral inflammation to central neurodegeneration.
Mult Scler Relat Disord
Baothman A, Al-Kuraishy HM, Elkady WA, Musa A, Batiha GE.
PMID: 42735600 [PubMed - as supplied by publisher]


Efficacy and safety of autologous hematopoietic stem cell transplantation (AHSCT) versus alemtuzumab in multiple sclerosis: Systematic review and individual patient data meta-analysis.
Mult Scler Relat Disord
Kebir N, Waleed S, Sayed YAE, Ali ME, Ayman H, Moubarak ES, El-Ramly TA, Abbas OF.
PMID: 42735599 [PubMed - as supplied by publisher]


Treatment fidelity and adherence in a pilot physical activity randomized controlled trial for people newly diagnosed with multiple sclerosis.
Mult Scler Relat Disord
Huynh TLT, Argie AA, Motl RW.
PMID: 42735598 [PubMed - as supplied by publisher]


Activated platelets in multiple sclerosis: Immunoinflammatory mechanisms and the therapeutic controversy of acetylsalicylic acid.
Mult Scler Relat Disord
Al-Jehani H, Al-Kuraishy HM, Elkady WA, Musa A, Batiha GE.
PMID: 42735596 [PubMed - as supplied by publisher]


Disease Course, Outcomes, and Complications in Pregnant and Breastfeeding Women with Multiple Sclerosis Treated with Rituximab or Ocrelizumab: A Narrative Review.
J Res Pharm Pract
Ashtari F, Momenzadeh M.
PMID: 42732421 [PubMed]


PET-MRI effects of N-acetylcysteine in patients with multiple sclerosis.
IBRO Neurosci Rep
Monti DA, Monadi SD, Mohamed FB, Alizadeh M, Zabrecky G, Wintering N, Gupta M, Steinmetz A, Kremens D, Bazzan AJ, Newberg AB.
PMID: 42732209 [PubMed]


The association of herpes simplex virus, epstein-barr virus, and cytomegalovirus infections with multiple sclerosis: a large-scale case-control study.
Brain Behav Immun
Nissan J, Fennig U, Tsikinovsky Y, Melcer K, Maggio N, Vinker S, Loebenstein R.
PMID: 42731602 [PubMed - as supplied by publisher]


Dipeptidyl peptidase-4 inhibitors and risk of multiple sclerosis: A Danish nationwide matched case-control study.
J Neuroimmunol
Erichsen PA, Heerfordt IM, Framke E, Magyari M, Horwitz H.
PMID: 42731377 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 44897    Page 1 of 2245  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1